Previous close | 18.10 |
Open | 17.96 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 17.91 - 18.35 |
52-week range | 10.89 - 24.50 |
Volume | |
Avg. volume | 3,029 |
Market cap | 5.079B |
Beta (5Y monthly) | 0.87 |
PE ratio (TTM) | 6.22 |
EPS (TTM) | 2.95 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 1.12 (6.99%) |
Ex-dividend date | 17 Aug 2023 |
1y target est | N/A |
JERSEY CITY, N.J., April 08, 2024--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
SHANGHAI, China & JERSEY CITY, N.J., April 08, 2024--Organon and Henlius announce that Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoint
JERSEY CITY, N.J., February 20, 2024--Organon Announces HADLIMA Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary